PEAK6 Group’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$3.28M Buy
73,900
+66,200
+860% +$3.29M 0.01% 1011
2018
Q1
$375K Sell
7,700
-15,800
-67% -$790K ﹤0.01% 2843
2017
Q4
$1.18M Sell
23,500
-45,800
-66% -$2.4M 0.01% 1794
2017
Q3
$3.51M Buy
69,300
+500
+0.7% +$23.6K 0.02% 985
2017
Q2
$2.61M Sell
68,800
-48,000
-41% -$1.89M 0.02% 1133
2017
Q1
$4.5M Buy
116,800
+46,900
+67% +$1.41M 0.04% 625
2016
Q4
$1.54M Buy
69,900
+17,000
+32% +$349K 0.01% 1513
2016
Q3
$846K Buy
52,900
+51,100
+2,839% +$584K 0.01% 1921
2016
Q2
$15K Sell
1,800
-1,400
-44% -$12.5K ﹤0.01% 4092
2016
Q1
$22K Buy
+3,200
New +$16.1K ﹤0.01% 4087

Other funds holding CC

PEAK6 Group's CC Position: Q2 2018 in Review

PEAK6 Group increased its Chemours (CC) stake by 25% in Q2 2018, buying an estimated $349K and bringing the position to 34,557 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #1587.

PEAK6 Group first reported a position in CC in Q3 2015 and has held it in 8 quarters since. 558 funds tracked by Wall St. Rank hold CC as of Q2 2018.

  • PEAK6 Group held 34,557 shares of Chemours worth $1.53M as of Q2 2018.
  • PEAK6 Group bought 7,010 Chemours shares in Q2 2018, an estimated $349K.
  • Chemours made up 0.01% of PEAK6 Group's portfolio in Q2 2018, its #1587 holding.
  • PEAK6 Group first reported a position in Chemours in Q3 2015 and has held it in 8 quarters since.
  • 558 funds tracked by Wall St. Rank held Chemours as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.